ARKG vs BIL
ARK Genomic Revolution ETF vs SPDR Bloomberg 1-3 Month T-Bill ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
BIL—
SPDR Bloomberg 1-3 Month T-Bill ETF
Ultra-short T-Bills, cash-equivalent.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | BIL |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | State Street |
ARKG top holdings
Holdings data unavailable for ARKG.
BIL top holdings
Holdings data unavailable for BIL.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About BIL
BIL (SPDR Bloomberg 1-3 Month T-Bill ETF) is Ultra-short T-Bills, cash-equivalent.